세계 주사형 약물전달 기기 시장 규모는 2024년 2,165억 달러에서 예측 기간 동안 CAGR 7.9%로 추이하고, 2029년에는 3,172억 달러에 이를 것으로 예측됩니다.
북미 시장은 2024년 773억 달러에서 예측 기간 동안 CAGR 6.2%로 추이하고, 2029년에는 1,044억 달러에 달할 것으로 예측되고 있습니다. 아시아태평양 시장은 2024년 567억 달러에 이르고, CAGR 9.5%로 추이하고 2029년에는 891억 달러에 이를 것으로 예측됩니다.
본 보고서에서는 세계의 주사형 약물전달 기기 시장을 조사했으며, 시장 개요, 시장 영향요인 및 시장 기회의 분석, 법규제 환경, 신기술 및 기술 개발의 동향, 시장 규모 추이와 예측, 각종 구분· 지역별 상세 분석, 경쟁 구도, 주요 기업 프로파일 등을 정리했습니다.
목차
제1장 주요 요약
제2장 시장 개요
- 개요
- PESTEL 분석
- Porter's Five Forces 분석
- 공급망 분석
제3장 시장 역학
- 개요
- 시장 성장 촉진요인
- 만성 질환 증가와 인구의 고령화
- 기술의 진보
- 환자의 자가 투여 선호도
- 생물 제제의 진보
- 시장 성장 억제요인
- 안전상의 우려
- 시장 기회
- 신흥 시장
- 시장의 과제
- 환자의 컴플라이언스와 수용
제4장 규제 상황
제5장 신기술과 개발
- 신흥기술
- 3D 프린팅
- 나노입자 전달 시스템
- 생분해성 및 지속 방출 시스템
- 특허 분석
- 연별 특허
- 출원인별 특허
- 소유자별 특허
- 발명자별 특허
- 관할별 특허
- 임상시험 분석
- 임상시험 분석 : 연구 유형별
- 임상시험 분석 : 상태별
- 임상시험 분석 : 위상별
제6장 시장 세분화 분석
- 부문별 내역
- 주사형 약물전달 기기 세계 시장
- 시장 분석 : 제품별
- 기존 주사기
- 첨단 주사기기
- 시장 분석 : 이용 유형별
- 일회용 주사기
- 재사용 가능 주사기
- 시장 분석 : 투여 경로별
- 피하
- 근육내
- 정맥내
- 피내
- 시장 분석 : 치료 용도별
- 당뇨병
- 종양
- 자가면역질환
- 기타
- 시장 분석 : 최종 사용자별
- 병원 및 진료소
- 재택 케어
- 기타
- 지리적 내역
- 시장 분석 : 지역별
- 북미
- 유럽
- 아시아태평양
- 기타 지역
제7장 지속가능성: 주사형 약물전달 기기 산업에서 ESG의 관점
- 개요
- ESG 데이터 이해
- 환경 성능
- 사회적 성능
- 거버넌스 퍼포먼스
- BCC에 의한 총론
제8장 경쟁 정보
- 개요
- 주사형 약물전달 기기 제조업체의 전략
- 유통 네트워크
제9장 부록
- 조사 방법
- 기업 프로파일
- AMGEN INC.
- ASTRAZENECA
- BD
- BAXTER
- B. BRAUN SE
- F. HOFFMANN-LA ROCHE LTD.
- GERRESHEIMER AG
- LILLY
- MERCK & CO. INC.
- MEDTRONIC
- PFIZER INC.
- SANOFI
- TEVA PHARMACEUTICAL INDUSTRIES LTD.
- TERUMO CORP.
- YPSOMED
- 약어
- 출처
JHS
The global market for injectable drug delivery device is estimated to increase from $216.5 billion in 2024 to reach $317.2 billion by 2029, at a compound annual growth rate (CAGR) of 7.9% from 2024 through 2029.
The North American market for injectable drug delivery device is estimated to increase from $77.3 billion in 2024 to reach $104.4 billion by 2029, at a CAGR of 6.2% from 2024 through 2029.
The Asia-Pacific market for injectable drug delivery device is estimated to increase from $56.7 billion in 2024 to reach $89.1 billion by 2029, at a CAGR of 9.5% from 2024 through 2029.
Report Scope:
This report covers the global market for injectable Drug Delivery Device. It provides market projections for 2029 and analyzes the injectable Drug Delivery Device market along the following parameters: product, usage type, route of administration, therapeutic application and end users. Based on product, the injectable Drug Delivery Device market is segmented into conventional devices and advanced injectable devices. Based on usage type, the market is segmented into disposable injectors and reusable injectors. Based on the route of administration, it is segmented into subcutaneous, intramuscular, intravenous and intradermal. Based on therapeutic application, the market is segmented into diabetes, oncology, autoimmune diseases and others. Based on end user, it is segmented into hospitals and clinics, home care settings and others. The report includes a detailed competitive landscape that covers major players, market share and recent strategic developments.
Additionally, the report breaks down market trends and growth prospects across different regions. It includes market forecasts, consumer insights and a thorough supply chain analysis. By addressing distribution channels, key suppliers and other such factors, the report aims to provide a comprehensive view of the market's current state and future potential as this can help stakeholders make informed decisions and identify strategic opportunities in the injectable drug delivery device industry.
Report Includes:
- 46 data tables and 62 additional tables
- Analyses of trends in the global market for injectable drug delivery devices, with market revenue data from 2021-2023, estimates for 2024 and projected CAGRs through 2029
- Estimates of the market size and revenue growth prospects, along with a market share analysis by product, therapeutic area (application), route of administration, end user and region
- Facts and figures pertaining to the market drivers, opportunities and challenges, emerging technologies and regulatory landscape
- A Porter's Five Forces model, and global supply chain and PESTLE analyses
- Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, and the ESG scores and practices of leading companies
- Review of patents and patent applications filed on drug delivery release mechanisms and novel applications
- A look at the pipeline drugs, clinical trial applications and potential markets for future developments
- Analysis of the competitive landscape, including companies' market shares, strategic alliances, M&A activities, and a venture funding outlook
- Company profiles of major players within the industry, including BD, Sanofi, Ypsomed, Lilly, Gerresheimer AG, Medtronic, Pfizer Inc.
Table of Contents
Chapter 1 Executive Summary
- Market Outlook
- Scope of Report
- Market Summary
Chapter 2 Market Overview
- Overview
- PESTEL Analysis
- Porter's Five Forces Analysis
- Supply Chain Analysis
- Raw Materials Sourcing
- Manufacturing
- Packaging and Labeling
- Distribution and Logistics
- Marketing, Sales, and End User
Chapter 3 Market Dynamics
- Overview
- Market Drivers
- Increasing Prevalence of Chronic Diseases and Aging Population
- Technological Advances
- Patient Preference for Self-Administration
- Advances in Biologics
- Market Restraints
- Safety Concerns
- Market Opportunities
- Emerging Markets
- Market Challenges
- Patient Compliance and Acceptance
Chapter 4 Regulatory Landscape
Chapter 5 Emerging Technologies and Developments
- Emerging Technologies
- 3D Printing
- Nanoparticle Delivery Systems
- Biodegradable and Sustained Release Systems
- Patent Analysis
- Patents by Year
- Patents by Applicant
- Patents by Owner
- Patents by Inventor
- Patents by Jurisdiction
- Clinical Trials Analysis
- Clinical Trials Analysis by Type of Study
- Clinical Trials Analysis by Status
- Clinical Trials Analysis by Phase
Chapter 6 Market Segmentation Analysis
- Segmental Breakdown
- Global Market for Injectable Drug Delivery Device
- Market Analysis by Product
- Conventional Injectable Devices
- Advanced Injectable Devices
- Market Breakdown by Usage Type
- Disposable Injectors
- Reusable Injectors
- Market Breakdown by Route of Administration
- Subcutaneous
- Intramuscular
- Intravenous
- Intradermal
- Market Breakdown by Therapeutic Application
- Diabetes
- Oncology
- Autoimmune Diseases
- Other Applications
- Market Breakdown by End User
- Hospital and Clinics
- Homecare Settings
- Others
- Geographic Breakdown
- Market Analysis by Region
- North America
- Europe
- Asia-Pacific
- Rest of the World
Chapter 7 Sustainability: An ESG Perspective in the Injectable Drug Delivery Device Industry
- Overview
- Understanding the ESG Data
- Environmental Performance
- Social Performance
- Governance Performance
- Concluding Remarks from BCC
Chapter 8 Competitive Intelligence
- Overview
- Strategies for Injectable Drug Delivery Device Manufacturers
- Distribution Networks
Chapter 9 Appendix
- Methodology
- Company Profiles
- AMGEN INC.
- ASTRAZENECA
- BD
- BAXTER
- B. BRAUN SE
- F. HOFFMANN-LA ROCHE LTD.
- GERRESHEIMER AG
- LILLY
- MERCK & CO. INC.
- MEDTRONIC
- PFIZER INC.
- SANOFI
- TEVA PHARMACEUTICAL INDUSTRIES LTD.
- TERUMO CORP.
- YPSOMED
- Abbreviations
- Sources
